LianBio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-87.98	-110.29	-196.3	-139.6
Depreciation & Amortization	1.25	1.31	0.42	0.08
Share-Based Compensation	18.52	19.15	8.66	5.18
Other Operating Activities	-15.32	-9.35	23.26	36.21
Operating Cash Flow	-83.53	-99.19	-163.95	-98.14
Capital Expenditures	-0.46	-1.85	-0.95	-0.89
Change in Investments	89.5	-67.36	-154.99	0
Investing Cash Flow	89.04	-69.2	-155.94	-0.89
Share Issuance / Repurchase	0	1.71	316.63	0
Debt Issued / Paid	0	0	0	15
Other Financing Activities	-	-	-3.36	294.75
Financing Cash Flow	0	1.71	313.27	309.75
Exchange Rate Effect	-0.92	-2.21	0.45	0.33
Net Cash Flow	4.59	-168.89	-6.17	211.05
Free Cash Flow	-83.99	-101.03	-164.9	-99.03
Free Cash Flow Per Share	-0.78	-0.94	-4.79	-8.22

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).